GG&G

[art2426]

>>>it seems the company got FDA to say that if they had three different body parts supported by clinical evidence then they would issue a general clearance.<<<


Thanks, UK, that pretty much explains the delay in the 'back patch'. Not at all disappointed in waiting. I thought this was going to play out this way: foot and knee first, then 'back'. A few more studies on other parts of the body should suffice. Don't mind waiting at all because this is going to be the BIG ONE. And gives us the opportunity and extra time to accumulate more shares. Probably the reason this did not take off after this first FDA OK, as most are waiting for that next clearance. ALL still good IMO!!